cold; 103 fever; sick; profuse sweating; This is a spontaneous report from a Contactable Consumer. This Consumer reported for a 17-Year-old Female Patient (Reporter daughter) that: A 17-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EW0162), via an unspecified route of administration, administered in left arm on 28Apr2021 (at the age of 17-years-old)  as DOSE 2, SINGLE for covid-19 immunization. Medical history included trauma surgery on left arm from 01Jul2020 to an unknown date. Broken elbow and multiple fractured bones (Trauma surgery on left arm, broken elbow and multiple fractured bones in her left arm. She has 2 plates in her arm) from 01Jul2021 to an unknown date. Surgery (Manipulation surgery) from 21Sep2021 to an unknown date. Birth control an unspecified date and unknown if ongoing. It was reported that patient has 2 plates in her arm. 2 separate surgeries. First surgery 01Jul2020. Manipulation surgery on 21Sep2020. She broke her distal humerus. Concomitant medication included ethinyl estradiol, ferrous fumarate, norethisterone acetate (JUNEL FE) taken for birth control, (Dosage text: 1/20, 1 tablet a day by mouth) start and stop date were not reported. Vaccine Administered at Military Facility: No. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available). Additional Vaccines Administered on Same Date of the Pfizer Suspect. If applicable, list all vaccines administered on same date with the Pfizer vaccine considered as suspect: None. Prior Vaccinations, patient did not receive any other vaccinations within four weeks prior to the first administration date of the suspect vaccine. AE(s) following prior vaccinations: None. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: ER8734), via an unspecified route of administration, administered in left arm on 07Apr2021 (at the age of 17-years-old) as DOSE 1, SINGLE for covid-19 immunization. On 29Apr2021 after the second dose of vaccination, the patient experienced sick and profuse sweating. On an unspecified date the patient experienced cold and 103 fever. The reporter stated that her 17-year-old daughter received the first dose of the Pfizer COVID-19 vaccine on 07Apr2021 and the second dose on 28April2021. After receiving the second dose, her daughter was sick for 48 hours and continues with issues of profuse sweating and has been going on since April. Reporter stated that her daughter shirts were soaked even if it was cold outside. Reporter also stated that, other people have reported it as well and wanted to report her daughter's experience so that it will be recorded as a possible side effect with the vaccine. Reporter wanted to know how long the side effects of Pfizer COVID-19 vaccine may last. On an unspecified date, the patient underwent lab tests and procedures which included body temperature: 103. The patient did not require to visit Emergency Room/Physician Office. Investigation Assessment: No. The outcome of event sick was recovered on 01May2021, the events profuse sweating was not recovered, while the outcome of events cold and 103 fever was unknown.